Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis

• Status: Withdrawn
• Trial end date: 2013-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates whether treatment with rosuvastatin on top of standard anti-coagulant treatment will decrease the risk of recurrent venous thromboembolism and arterial thromboembolic events in patients with previous deep vein thrombosis or pulmonary embolism.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Rosuvastatin Calcium

Criteria

Inclusion Criteria:

• Signed informed Consent.

• Patients with venous thromboembolism who are treated with anti-coagulant according to the current guidelines

Exclusion Criteria:

• Patients in need of or already treated with lipid lowering drugs

• Active liver or kidney disease or dysfunction or muscle disorders

• Unstable medical or psychological condition that interferes with study participation

• Pregnant woman or woman with childbearing potential who are not willing to use contraception

• History of statin-related muscular pain, or hypersensitivity to statins